NCT05509751Active, not recruiting
The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person
Supporting Older Adults With Cancer and Their Support Person Through Geriatric Assessment and Remote Exercise and Education: the SOAR Study
Source: ClinicalTrials.gov · Last updated 28 Apr 2026
Brief summary (registry, in English)
Phase 2 randomized controlled study using a waitlist control group. The study also has a single arm pre-post test 12-week chair-based exercise arm for those who have received the geriatric assessment in the older adults with cancer clinic (geriatric oncology clinic). Study Duration 2.5 years Study Agent/ Intervention/ Procedure Comprehensive Geriatric Assessment and Management (GAM) combined with online chair-based exercise (CBE) and health education for 12 weeks.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 15 Aug 2022
- Start date
- 1 Oct 2023
- Primary completion date
- 1 Mar 2026
- Lead sponsor
- Martine Puts
- Diseases
- Lung cancer
- NCT number
- NCT05509751
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Oct 2023 to the primary completion date, 1 Mar 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Clinic visit with a geriatrician in the previous 12 months (they have already received part of the intervention).
Other illness
- Severe neuropsychiatric abnormalities (e.g., moderate-severe dementia) per the treating physician; and
Other
- Chest tube in-situ.
- Not able to give informed consent.
Who the study is looking for
- Aged 65+ years.
- Diagnosed with lung, gastrointestinal (GI) , breast, Gynecologic or Genitourinary (GU) cancer or lymphoma who are referred for chemotherapy or immunotherapy and have not received \> 4 weeks of systemic treatment.
- 4\) Have a physician estimated life expectancy of \>6 months. 5) Be physically inactive (no more than 90 min moderate to vigorous activity per week as per GLTEQ and do not currently meet the recommended physical activity volume of 90 min of aerobic exercise/week).
- 6\) Able to speak and understand English. 7) Able to give informed consent. 8) Are considered safe to participate in the weekly classes as per their treating oncologist.
- Eligible support persons are:
- Identified by the older adult as their support person.
- Aged 18 years and over.
- Able to speak and understand English.
- Able to give informed consent.
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sunybrook Health Sciences Centre, Odette Cancer Centre Coordinator of this site? Confirm its status | Toronto | Canada | Unknown status |
| Princess Margaret Cancer Centre Coordinator of this site? Confirm its status | Toronto | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.